BriaCell Therapeutics Corp (NASDAQ: BCTX) has announced the presentation of results from clinical studies evaluating its lead product candidate, Bria-IMT, at the American Association for Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback